Abstract
Hyperuricaemia is a common complication of diuretic use in man and its simple elimination as a side effect would be an advantage. The finding that the indanone diuretic, MK-196, was actually uricosuric in the chimpanzee (Fanelli et alii, 1974), was of potential importance to human therapeutics. Initial studies had confirmed that a 10 mg dose was diuretic in healthy volunteers but had very little effect upon the serum urate concentration. An important question therefore was to decide whether larger doses of the drug would have a greater uricosuric effect without a corresponding increase in the natriuretic or kaluretic effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
FANELLI, G.M., BOHN, D.L., HORBATY, C.A., BEYER, K.H. and SCRIABINE, A. Kidney International 6:40A (1974).
STEELE, T.H. and OPPENHEIMER, S. Am. J. Med. 47:564–574 (1969).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Emmerson, B.T., Thompson, L., Mitchell, K. (1977). Dose-Response Relationship of a Uricosuric Diuretic. In: Müller, M.M., Kaiser, E., Seegmiller, J.E. (eds) Purine Metabolism in Man—II. Advances in Experimental Medicine and Biology, vol 76B. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3285-5_48
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3285-5_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3287-9
Online ISBN: 978-1-4684-3285-5
eBook Packages: Springer Book Archive